📜 iter-4360dd15-0011.log
12985 bytes
# Iter-0011 mission=4360dd15
# goal: 找到让人类长生不老的方法
# time: 2026-04-25T22:55:41
# focus_node: n118 :: 审计 IL-1 / MyD88 轴是否比 TNF/IL-6 更值得优先
========== TRANSCRIPT ==========
→ call task_view({"max_depth":6})
【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n· [✓ done ] root: 找到让人类长生不老的方法\n├─ [✓ done ] n1: 建立 marker 锚定后的局部交换判定框架 ← 已完成 marker 锚定后的局部交换判定框架：固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口，并在触及 wit\n│ ├─ [✓ done ] n5: 规范化 witness：固定 μ 锚点并限制一次交换的位置 ← 完成 witness 规范化：确认固定 μ 锚点时必须排除触碰 μ 的交换，并用 greedy witness span 将允许交换压缩到局部窗口内；小规模穷举\n│ │ ├─ [✓ done ] n9: 证伪一次交换跨越 μ 的规范化可能性 ← 用穷举验证并归纳出结构性事实：任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1，因此在固定 μ 位置的 witness 规范化里，不存在“跨\n│ │ ├─ [✓ done ] n10: 把单侧交换位置压缩为可判定窗口 ← 证明并穷举验证：对左块 greedy witness 的最左/最右嵌入位置 p1..pk，窗口外相邻交换不会改变最大前缀消耗 k，因此允许交换位置可压缩为 [p\n│ │ └─ [✓ done ] n11: 沉淀 witness 规范形模板 ← 沉淀出 witness 规范形模板：固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口，并用左块最大前缀消耗 k 作\n│ ├─ [✓ done ] n6: 建立单侧切分判定接口：把可行性压成存在切分点 k ← 把固定 μ 锚点后的可行性压成了单侧切分接口：左块只通过最大前缀消耗长度 k 传递，且 k 由 X 决定、与 Y 无关。\n│ ├─ [✓ done ] n7: 刻画交换不依赖右侧的充分条件 ← 验证了一个可复用充分条件：若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k，则对所有右侧 Y 的可行性判定保持不变；并用穷举检查了 small-case \n│ ├─ [✓ done ] n8: 沉淀可复用的验证模板与失败边界 ← 找到验证模板的失败边界：任意 witness span 不够，必须用 greedy witness span；给出反例 X=abb, S=ba，窗口外交换仍可改\n│ ├─ [✓ done ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界 ← 在二元字母表、长度 n<=8 的穷举中，未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例；这给出了多交换局部性边\n│ ├─ [✓ done ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程 ← 完成了一个可执行的局部交换检查流程：先算 k，再用 greedy witness span 的局部闭包限制候选交换；对二元字母表、|X|<=8、|S|<=8 的\n│ ├─ [✓ done ] n14: 证伪 greedy witne
→ call search_memory({"limit":8,"mission_only":false,"query":"complement cascade aging inflammaging longevity bottleneck"})
【tool:search_memory】
{"ok": true, "results": [{"title": "complement 轴是高潜力候选但尚非 universal longevity bottleneck", "tags": "fact lesson aging immunology principle", "mission": "", "modified": "20260425143032000", "preview": "!! Complement axis is a plausible but not yet universal longevity bottleneck ''结论'': complement 轴显示出较强的系统性 inflammaging 相关性；例如 calorie-restricted humans 的 exoproteome 研究把 complement deactivation 描述为 immunometabolic checkpoint，而 C3 deficiency 可改善老龄小鼠肾脏相关改变。但截至当前未检到直接的 whole-body 寿命/健康寿命原始因果证据，因此它应被视为''高潜力候选''，而不是已证实的 universal longevity bottleneck。 ''方法教训'': 对免疫/炎症候选的升级标准应继续坚持：优先找原始因果干预 + 直接寿命/健康寿"}, {"title": "TNF/IL-6 are low-priority control axes in longevity bottleneck screening", "tags": "fact lesson principle aging immunology", "mission": "", "modified": "20260425145355000", "preview": "!! TNF/IL-6 should stay as low-priority control axes in longevity bottleneck screening ''结论'': 在筛选免疫/炎症相关长寿入口时，TNFα 与 IL-6 这类经典促炎细胞因子应默认视为//低优先级对照轴//，除非能证明它们在多个组织、多个衰老表型上同时充当上游总开关。 ''判断规则'': # 看到“炎症强、通路热、甚至有局部寿命改善”时，不要自动升级为 universal bottleneck。 # 只有当扰动后能跨组织恢复多类功能，并且最好有健康寿命/寿命终点支持，才值得从“相关促炎因子”升格为“长寿主靶点”。 ''对照意义'': TNF/IL-6 的价值主要在于防止把经典炎症读出误判为更上游瓶颈；更值得继续审计的上游候选通常是 [[cGAS-STING]]、[[complement casc"}, {"title": "NEXT_FOCUS", "tags": "pinned focus", "mission": "4360dd15", "modified": "20260425145413000", "preview": "!! 下轮焦点（来自 mission `4360dd15` · Iter-0010） [n117] 审计 complement cascade 是否能升级为长寿瓶颈（路径：找到让人类长生不老的方法 > 筛选免疫/炎症相关的下一个高杠杆长寿瓶颈候选 > 审计 complement cascade 是否能升级为长寿瓶颈）"}, {"title": "IL-1
→ call search_memory({"limit":5,"mission_only":false,"query":"complement C3 C1q aging longevity healthspan mouse lifespan"})
→ call pubmed_search({"limit":8,"query":"(complement OR C3 OR C1q OR C5) aging lifespan healthspan mouse"})
→ call web_search({"limit":8,"query":"complement aging lifespan healthspan C3 C1q mouse review"})
【tool:search_memory】
{"ok": true, "results": [{"title": "C1q is aging-associated but not yet a universal longevity bottleneck", "tags": "fact lesson principle aging immunology", "mission": "", "modified": "20260425125313000", "preview": "!! C1q/complement 轴：有强 aging 关联，但目前仍不足以升级为通用长寿瓶颈 ''结论'': C1q 在小鼠和人脑中会随年龄显著升高，并能激活 Wnt/β-catenin、促进组织再生衰退、神经突触修剪和某些炎症/代谢病理；但现有公开证据主要停留在病理/再生读出与疾病模型，未见直接的 healthspan/lifespan 终点，因此更适合被视为 //inflammaging// 的执行/放大回路，而不是已证实的通用上游长寿瓶颈。 ''审稿式警告'': 只要证据链仍是“年龄上升 → 分子变化 → 局部病理改善/恶化”，就不要把它自动升级为“寿命总开关”；必须补上多器官健康寿命或寿命终点才可改判。"}, {"title": "C1q brain aging mechanism is informative but still insufficient for universal longevity candidacy", "tags": "fact lesson principle aging immunology", "mission": "", "modified": "20260425131714000", "preview": "!! C1q brain aging mechanism is informative but still insufficient for universal longevity candidacy ''结论'': 2024 Cell 研究显示，微胶质来源 C1q 可在衰老脑中被神经元内吞并与 neuronal RNP complexes 发生 RNA-dependent 互作，进而改变蛋白翻译与蛋白稳态；C1q 缺失还能带来 age-specific 的神经元蛋白合成变化和记忆消退缺陷。 ''可复用判断'': 即便某个 aging factor 已经具备清晰的跨细胞/跨亚细胞机制，只要证据仍主要落在单器官（尤其是脑）内的分子/行为读出，而缺少多器官 healthspan 或 lifespan 终点，就不应把它升级为通用长寿瓶颈。"}, {"title": "complement 轴是高潜力候选但尚非 universal longevity bottleneck", "tags": "fact lesson aging immunology principle", "mission": "", "modified": "20260425143032000", "preview": "!! Complement axis is a plausible but not yet universal longevity bottleneck ''结论'': complement 轴显示出较强的系统性 inflammaging 相关性；例如 calorie-restricted humans 的 exoproteome 研究把 complement deactivation 描
【tool:pubmed_search】
{"ok": true, "query": "(complement OR C3 OR C1q OR C5) aging lifespan healthspan mouse", "results": [{"pmid": "41974968", "title": "Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging.", "source": "Nat Aging", "pubdate": "2026 Apr 13", "authors": ["Mishra M", "Kim HH", "Youm YH", "Gonzalez-Hurtado E", "Zaitsev K", "Dlugos T", "Shchukina I", "Gliniak C"], "url": "https://pubmed.ncbi.nlm.nih.gov/41974968/"}, {"pmid": "40799539", "title": "Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging.", "source": "bioRxiv", "pubdate": "2025 Dec 2", "authors": ["Mishra M", "Kim HH", "Youm YH", "Gonzalez-Hurtado E", "Zaitsev K", "Dlugos T", "Shchukina I", "Gliniak C"], "url": "https://pubmed.ncbi.nlm.nih.gov/40799539/"}, {"pmid": "40774052", "title": "Beyond the 900-day rule: Reclaiming healthspan as geroscience's primary goal.", "source": "Ageing Res Rev", "pubdate": "2025 Dec", "authors": ["Verlinden SF"], "url": "https://pubmed.ncbi.nlm.nih.gov/40774052/"}, {"pmid": "37487005", "title": "Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span.", "source": "Aging (Albany NY)", "pubdate": "2023 Jul 23", "authors": ["Kaverina N", "Schweickart RA", "Chan GC", "Maggiore JC", "Eng DG", "Zeng Y", "McKinzie SR", "Perry HS"], "url": "https://pubmed.ncbi.nlm.nih.gov/37487005/"}, {"pmid": "30334314", "title": "Progra
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
→ call pubmed_search({"limit":10,"query":"C3 deficiency aging mouse healthspan kidney complement"})
【tool:pubmed_search】
{"ok": true, "query": "C3 deficiency aging mouse healthspan kidney complement", "results": []}
→ call pubmed_search({"limit":10,"query":"C1q aging mouse healthspan lifespan complement"})
→ call pubmed_search({"limit":10,"query":"C3 deficiency aging mouse kidney healthspan complement"})
→ call pubmed_search({"limit":10,"query":"complement cascade longevity mouse lifespan healthspan original study"})
【tool:pubmed_search】
{"ok": true, "query": "C1q aging mouse healthspan lifespan complement", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "C3 deficiency aging mouse kidney healthspan complement", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "complement cascade longevity mouse lifespan healthspan original study", "results": []}
→ call write_note({"tags":["fact","lesson","principle","aging","immunology"],"text":"!! Complement cascade remains a high-potential but not yet universal longevity bottleneck\n''结论'': 补体级联（尤其 C1q/C3 相关轴）可以作为系统性 inflammaging 放大器候选，但截至当前公开证据仍不足以把它升级为//通用长寿瓶颈//。\n\n''本轮审计要点'':\n# PubMed 可检到 [[PMID 41974968]]：calorie-restricted humans 的 exoproteome 研究把 complement deactivation 描述为 reducing inflammaging 的 immunometabolic)
【tool:write_note】
{"ok": true, "path": "/root/Sisyphus/wiki/tiddlers/Complement_cascade_remains_a_high-potential_but_not_yet_universal_longevity_bottleneck.tid", "title": "Complement cascade remains a high-potential but not yet universal longevity bottleneck"}
→ call task_done({"id":"n117","result":"审计完成：补体级联可视为全身性 inflammaging 放大器候选，但仅检到 calorie-restricted humans 的 complement deactivation 线索与若干病理/机制关联，未找到直接支持 whole-body healthspan/lifespan 的原始因果证据，因此不应升级为 universal longevity bottleneck。"})
【tool:task_done】
{"ok": true, "id": "n117", "status": "done", "next_focus": "n118"}
【assistant】
已完成本轮审计：补体级联目前仍应视为“高潜力候选”，但证据不足以升级为通用长寿瓶颈。
<NEXT_FOCUS>审计 IL-1 / MyD88 轴是否比 TNF/IL-6 更值得优先</NEXT_FOCUS>
========== REFLECTION ==========
{
"progress": "完成了对补体级联的审计，确认其仍停留在 inflammaging 候选层级，未找到可升级为通用长寿瓶颈的原始因果证据。",
"failure": "网络检索失败且 PubMed 未返回直接寿命/健康寿命原始研究，导致证据链仍主要停留在间接关联。",
"lesson": {
"worthy": false,
"title": "",
"tags": [
"lesson",
"failure"
],
"text": ""
},
"next_focus": "审计 IL-1/MyD88 轴是否存在跨组织、带健康寿命或寿命终点的上游因果证据，优先找原始干预研究。"
}